Venclose

Venclose

Medical Devices, 2570 N 1st St, San Jose, California, 95131, United States, 11-50 Employees

venclose.com

  • twitter
  • LinkedIn

phone no Phone Number: 84********

Who is VENCLOSE

We are a medical technology company developing next-generation solutions for the treatment of chronic venous insufficiency, a progressive medical condition affecting an estimated 10% of a...

Read More

map
  • 2570 N 1st St, San Jose, California, 95131, United States Headquarters: 2570 N 1st St, San Jose, California, 95131, United States
  • 2014 Date Founded: 2014
  • 11-50 Employees: 11-50
  • dollar-icon Revenue: $10 Million to $25 Million
  • tech-icon Active Tech Stack: See technologies

industries-icon Industry: Medical Devices

SIC SIC Code: 7389

checked-icon Does something look wrong? Fix it. | View contact records from VENCLOSE

Venclose Org Chart and Mapping

Employees

Gabriella Young

Associate Territory Manager

Mary Crimmins

Territory Sales Manager

Caley Reynolds

Territory Sales Manager

Mai-Ly Wilcox

Senior Director Regulatory and Clinical Affairs

Sean Collins

Area Vice President of Sales

Paul Tyska

Territory Sales Manager

Marty Munn

Territory Sales Manager

Rachel M

Director of Operations

signout-image
You are signed out

Sign in to CIENCE GO Data to uncover contact details

crown-icon Free credits every month

Frequently Asked Questions Regarding Venclose

Answer: Venclose's headquarters are located at 2570 N 1st St, San Jose, California, 95131, United States

Answer: Venclose's phone number is 84********

Answer: Venclose's official website is https://venclose.com

Answer: Venclose's revenue is $10 Million to $25 Million

Answer: Venclose's SIC: 7389

Answer: Venclose has 11-50 employees

Answer: Venclose is in Medical Devices

Answer: Venclose contact info: Phone number: 84******** Website: https://venclose.com

Answer: We are a medical technology company developing next-generation solutions for the treatment of chronic venous insufficiency, a progressive medical condition affecting an estimated 10% of adults. Our Mission To improve the physician and patient experience during chronic venous insufficiency treatment by commercializing the next-generation RF therapy.

Answer:

Premium Sales Data for Prospecting

  • Sales data across over 200M records

  • Up-to-date records (less decayed data)

  • Accurate Email Lists (real-world tested)

  • Powerful search engine and intuitive interface

lock icon Get Full Access